logo

Ipsen | Sustainability & Chart

FR0010259150

Basic information on Ipsen

Location: France

Industry: Health Services

Website

knob-globe
63%

Impact Score

Description Ipsen

Ipsen SA is a global biopharmaceutical company focused on innovation in oncology, rare diseases, and neuroscience, with a commitment to improving the quality of life for patients worldwide.

Ipsen Sustainability Performance

Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare Ipsen with ...

Ipsen

?

Impact Score

knob-globe
63%
knob-globe
0%
Climate
Society
Gender

Sources of sustainability performance

MetricValueUnitYearPDF NamePDF Page
CEO Pay Ratio
CEO nameDavid Loew2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf457
CEO-to-median-salary-ratio56,7Ratio2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf309
Employee Turnover Rate
Employee turnover14,3%2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf304
Gender Pay Gap
Unadjusted gender pay gap15,9%2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf309
Glass Ceiling
Number of employees5 535people2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf107
Women in management53,3(%)2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf312
Women in workforce3 399(headcount)2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf297
Greenhouse Gas Emissions
Number of employees5 535people2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf107
Scope 2 emissions, location based5 899(tCO2eq)2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf259
Scope 1 emissions8 638tCO2eq2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf259
Harassment and Discrimination at the Workplace
Anti-discrimination policyYes2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf349
Retaliation safeguardsYes2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf283
Confidentiality mechanismsYes2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf352
Incident notification mechanismYes2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf343
Renewable Energy
Total renewable energy consumption53%2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf249
Supply Chain
Number of employees5 535people2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf107
Scope 2 emissions, location based5 899(tCO2eq)2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf259
Scope 3 emissions101 734(tCO2eq)2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf259
Scope 1 emissions8 638tCO2eq2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf259
Union Formation and Collective Bargaining Power
Collective bargaining agreements coverage36%2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf299
Women on Board
Women on executive board50%2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf460
Supervisory board size14people2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf421
Women on supervisory board42%2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf190
Executive board size14people2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf189
Women in Management
Women in management53,3(%)2025EN_IPSEN-SA_UNIVERSAL-REGISTRATION-DOCUMENT-2025-1.pdf312
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

logo
© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev